SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Incorporation of uncertainty in health economic modelling studies
16 references·0 citing·31 second hop
Incorporation of uncertainty in health economic modelling studies (2005)Incorporation of uncertainty in health ec…Methods for the Economic Evaluation of Health Care Programmes (2005)Methods for the Economic Eval…Expected Value of Sample Information Calculations in Medical Decision Modeling (2004)Expected Value of Sample Info…Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies (2003)Principles of Good Practice f…Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosisCommentary: Evaluating disease modifying treatments in multiple sclerosis (2003)Modelling the cost effectiven…Probabilistic Analysis of Cost-Effectiveness Models: Choosing between Treatment Strategies for Gastroesophageal Reflux Disease (2002)Probabilistic Analysis of Cos…Economic Evaluation in Health Care: Merging Theory with Practice (2002)Economic Evaluation in Health…A rational framework for decision making by the National Institute For Clinical Excellence (NICE) (2002)A rational framework for deci…Representing uncertainty: the role of cost‐effectiveness acceptability curves (2001)Representing uncertainty: the…Handling uncertainty in economic evaluation and presenting the results (2001)Handling uncertainty in econo…Handling Uncertainty in Cost-Effectiveness Models (2000)Handling Uncertainty in Cost-…Assessing Quality in Decision Analytic Cost-Effectiveness Models (2000)Assessing Quality in Decision…Net Health Benefits (1998)Net Health BenefitsConfidence intervals or surfaces? Uncertainty on the cost-effectiveness plane (1998)Confidence intervals or surfa…Costs, effects and C/E‐ratios alongside a clinical trial (1994)Costs, effects and C/E‐ratios…Methods for the economic evaluation of health care programmes (1987)Methods for the economic eval…Probabilistic Sensitivity Analysis Using Monte Carlo Simulation (1985)Probabilistic Sensitivity Ana…Decision Analysis: Introductory Lectures on Choices Under Uncertainty. (1969)Judgment under Uncertainty: Heuristics and Biases (1974)Clinical Decision Analysis (1980)The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance (2005)A Guide to Simulation (1983)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions (2004)Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report (2015)Measurement of health state utilities for economic appraisal (1986)Markov Models in Medical Decision Making (1993)Cost-Effectiveness in Health and Medicine (1996)Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment (2006)An Introduction to Markov Modelling for Economic Evaluation (1998)The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies (1999)Bayesian Methods for Evidence Synthesis in Cost-Effectiveness Analysis (2006)Whither trial‐based economic evaluation for health care decision making? (2006)Increasing risk II: Its economic consequences (1971)The Analytics of Uncertainty and Information (1992)American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options (2015)Review of guidelines for good practice in decision-analytic modelling in health technology assessment (2004)The CarerQol instrument: A new instrument to measure care-related quality of life of informal caregivers for use in economic evaluations (2006)State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3 (2012)The estimation of a preference-based measure of health from the SF-36 (2002)Systematic reviews: CRD's guidance for undertaking reviews in health care (2010)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)The Estimation of a Preference-Based Measure of Health From the SF-12 (2004)Estimating mean QALYs in trial‐based cost‐effectiveness analysis: the importance of controlling for baseline utility (2004)Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices—Budget Impact Analysis (2007)Model Transparency and Validation (2012)Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1 (2012)
this work references cited by second hop

References

  • 2005Methods for the Economic Evaluation of Health Care Programmes13,647 cited
  • 1987Methods for the economic evaluation of health care programmes4,274 cited
  • 2003Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies1,170 cited
  • 2001Representing uncertainty: the role of cost‐effectiveness acceptability curves1,111 cited
  • 1998Net Health Benefits1,104 cited
  • 1994Costs, effects and C/E‐ratios alongside a clinical trial963 cited
  • 1985Probabilistic Sensitivity Analysis Using Monte Carlo Simulation860 cited
  • 2000Handling Uncertainty in Cost-Effectiveness Models806 cited
  • 2002Economic Evaluation in Health Care: Merging Theory with Practice721 cited
  • 2002A rational framework for decision making by the National Institute For Clinical Excellence (NICE)455 cited
  • 2002Probabilistic Analysis of Cost-Effectiveness Models: Choosing between Treatment Strategies for Gastroesophageal Reflux Disease413 cited
  • 1998Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane397 cited
  • 2004Expected Value of Sample Information Calculations in Medical Decision Modeling365 cited
  • 2000Assessing Quality in Decision Analytic Cost-Effectiveness Models212 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2003Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosisCommentary: Evaluating disease modifying treatments in multiple sclerosis142 cited
  • 2001Handling uncertainty in economic evaluation and presenting the results132 cited
  • Cited by

    No citing works inside the corpus for this window.